Becton Dickinson Net Worth 2010-2023 | BDX

Interactive chart of historical net worth (market cap) for Becton Dickinson (BDX) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Becton Dickinson net worth as of April 18, 2024 is $67.09B.
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $67.086B $19.372B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $69.110B 18.50
West Pharmaceutical Services (WST) United States $27.625B 46.70
Cardinal Health (CAH) United States $25.909B 15.57
Align Technology (ALGN) United States $22.586B 45.54
Cooper (COO) United States $17.860B 27.03
Labcorp (LH) United States $16.823B 14.37
Henry Schein (HSIC) United States $9.019B 15.60
DENTSPLY SIRONA (XRAY) United States $6.296B 16.59
Merit Medical Systems (MMSI) United States $4.152B 23.76
Patterson (PDCO) United States $2.305B 11.04
STAAR Surgical (STAA) United States $2.264B 71.29
CONMED (CNMD) United States $2.240B 21.09
Atrion (ATRI) United States $0.702B 36.15
Lifevantage (LFVN) United States $0.085B 13.75
Pro-Dex (PDEX) United States $0.064B 24.35
Biolase (BIOL) United States $0.005B 0.00